Low-dose cyclophosphamide enhances antigen-specific CD4+ T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma
Crossref DOI link: https://doi.org/10.1007/s00262-015-1656-x
Published Online: 2015-02-07
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Klein, Oliver
Davis, Ian D.
McArthur, Grant A.
Chen, Li
Haydon, Andrew
Parente, Phillip
Dimopoulos, Nektaria
Jackson, Heather
Xiao, Kun
Maraskovsky, Eugene
Hopkins, Wendie
Stan, Rodica
Chen, Weisan
Cebon, Jonathan
Text and Data Mining valid from 2015-02-07